MedPath

Clinical and radiographic evaluation of applying 1.2% Atorvastatin gel with plasma rich in growth factor (PRGF) for treatment of class II furcation involvement

Phase 3
Conditions
furcation grade 2 involvement of lower jaw molars.
Registration Number
IRCT20100427003813N7
Lead Sponsor
Babol University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
24
Inclusion Criteria

Patients with moderate to severe chronic periodontitis with severe grade II fractures on the buccal or lingual side of the first or second mandibular molars
The horizontal probing depth of the probes in the affected areas is greater than or equal to 3mm

Exclusion Criteria

Systemic disease
The need for prophylactic antibiotics to prevent bacterial endocarditis
Use of intermittent drugs with periodontal improvement
smoking
presence of contraindication for periodontal surgery
dental anatomical complications such as accessory canal concavity CEP, bifurcation ridge
Tooth mobility more than Grade II
The presence of decay and filling in the area of ??forcation
There is evidence of periapical pathology in the clinical or radiographic view of the tooth
Possibility of unaccompanied consent after initial periodontal treatment

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Grade 2 furcation involvement of lower jaw molars. Timepoint: Immediately before surgery 3 and 6 months after surgery. Method of measurement: periodontal probe.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath